,
De Meulder, Bertrand http://orcid.org/0000-0002-2108-7657
Lefaudeux, Diane
Bansal, Aruna T.
Mazein, Alexander
Chaiboonchoe, Amphun
Ahmed, Hassan
Balaur, Irina
Saqi, Mansoor
Pellet, Johann
Ballereau, Stéphane
Lemonnier, Nathanaël
Sun, Kai
Pandis, Ioannis
Yang, Xian
Batuwitage, Manohara
Kretsos, Kosmas
van Eyll, Jonathan
Bedding, Alun
Davison, Timothy
Dodson, Paul
Larminie, Christopher
Postle, Anthony
Corfield, Julie
Djukanovic, Ratko
Chung, Kian Fan
Adcock, Ian M.
Guo, Yi-Ke
Sterk, Peter J.
Manta, Alexander
Rowe, Anthony
Baribaud, Frédéric
Auffray, Charles
Funding for this research was provided by:
Innovative Medicines Initiative (U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, eTRIKS IMI n°115446, U-BIOPRED IMI n°115010, eTRIKS IMI n°115446, U-BIOPRED IMI n°115010, eTRIKS IMI n°115446, U-BIOPRED IMI n°115010, eTRIKS IMI n°115446, eTRIKS IMI n°115446, eTRIKS IMI n°115446, eTRIKS IMI n°115446, eTRIKS IMI n°115446, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, eTRIKS IMI n°115446, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, U-BIOPRED IMI n°115010, eTRIKS IMI n°115446)
Article History
Received: 20 July 2017
Accepted: 21 February 2018
First Online: 29 May 2018
Ethics approval and consent to participate
: Not applicable
: Not applicable
: ATB received fees from Acclarogen Ltd. KK received fees from UCB Celltech Ltd. JvE received fees from UCB Pharma S.A. AB received fees from Roche Products Ltd. TD received fees from Janssen R & D High Wycombe Ltd. PD received fees from AstraZeneca Ltd. CL received fees from GSK Ltd. JC received fees from Areteva R & D Ltd. AMan received fees from Roche Diagnostics GmbH, AR received fees from Janssen R & D High Wycombe Ltd. FB received fees from Janssen R & D Springhouse LLC.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.